Correlation Between PharmaEngine and Medigen Vaccine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PharmaEngine and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PharmaEngine and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PharmaEngine and Medigen Vaccine Biologics, you can compare the effects of market volatilities on PharmaEngine and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PharmaEngine with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of PharmaEngine and Medigen Vaccine.

Diversification Opportunities for PharmaEngine and Medigen Vaccine

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between PharmaEngine and Medigen is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding PharmaEngine and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and PharmaEngine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PharmaEngine are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of PharmaEngine i.e., PharmaEngine and Medigen Vaccine go up and down completely randomly.

Pair Corralation between PharmaEngine and Medigen Vaccine

Assuming the 90 days trading horizon PharmaEngine is expected to generate 10.47 times less return on investment than Medigen Vaccine. But when comparing it to its historical volatility, PharmaEngine is 1.46 times less risky than Medigen Vaccine. It trades about 0.07 of its potential returns per unit of risk. Medigen Vaccine Biologics is currently generating about 0.5 of returns per unit of risk over similar time horizon. If you would invest  3,525  in Medigen Vaccine Biologics on November 3, 2024 and sell it today you would earn a total of  1,380  from holding Medigen Vaccine Biologics or generate 39.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

PharmaEngine  vs.  Medigen Vaccine Biologics

 Performance 
       Timeline  
PharmaEngine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PharmaEngine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, PharmaEngine is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Medigen Vaccine Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Medigen Vaccine showed solid returns over the last few months and may actually be approaching a breakup point.

PharmaEngine and Medigen Vaccine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PharmaEngine and Medigen Vaccine

The main advantage of trading using opposite PharmaEngine and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PharmaEngine position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.
The idea behind PharmaEngine and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments